Israel · Delayed Price · Currency is ILS · Price in ILA Dna Group (T.R.) Company Description
Dna Group (T.R.) Ltd, together with its subsidiaries, engages in the development, manufacturing, and marketing of patented ultrasound systems in Israel, North America, East Asia, and internationally.
It provides systems for diagnosing bone strength and density, as well as for monitoring calcium leakage (osteoporosis) in adults and children.
The company offers its products for use by skilled physicians, nurses, and operators in hospitals and clinics, as well as in pharmacies and other places.
In addition, it engages in the development of oral drugs. The company was formerly known as D.N.A Biomedical Solutions Ltd. and changed its name to Dna Group (T.R.) Ltd in November 2022.
Dna Group (T.R.) Ltd was incorporated in 2004 and is based in Tel Aviv-Yafo, Israel.
Contact Details
Address: Shimon Hatars' 43 Tel Aviv, 6249245 Israel | |
| Phone | 972 54 233 6280 |
Stock Details
| Ticker Symbol | DNA |
| Exchange | Tel Aviv Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | ILS |
| ISIN Number | IL0011038523 |
| SIC Code | 3669 |
Key Executives
| Name | Position |
|---|---|
| Tal Marom | Chief Executive Officer of BeamMed |
| Erez Navon | Chairman of the Board and Chief Executive Officer |
| Tony Klein | Chief Financial Officer and Vice President of Finance |
| Zvika Ben Praz LTC (ret) | Vice President of Operations and Programs |
| Dr. Michael Gaft | Chief Scientist |